OPTION SAFE: Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05838690
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
3,000
8
2
51
375
7.4

Study Details

Study Description

Brief Summary

The purpose of the study is to assess the impact of a personalized intubation planning tool, the Personalized INtubation Safety (PINS) Bundle on intubation procedural safety and clinical outcomes among patients intubated in the neonatal intensive care unit (NICU) setting.

Condition or Disease Intervention/Treatment Phase
  • Other: Personalized Intubation Safety (PINS) Bundle
N/A

Detailed Description

Tracheal intubation (TI) in the neonatal intensive care unit (NICU) is frequently complicated by adverse safety outcomes such as adverse tracheal intubation associated events, multiple TI attempts, and oxygen desaturation. Investigators have developed, refined, and tested a Personalized INtubation Safety (PINS) Bundle that targets a prospective and individualized approach to TI planning and management. The Prospective Intubation Safety (PINS) Bundle addresses 5 core evidence-based domains that are individualized to the patient to develop a prospective, personalized and comprehensive multidisciplinary TI plan: (1) patient risk assessment; (2) treatment threshold for intubation; (3) premedication (promoting paralytic medication); (4) equipment (promoting video laryngoscope); (5) provider selection and escalation plan.

This is a pragmatic stepped wedge cluster randomized trial of NICU patients who are intubated across 8 participating hospitals to determine if the PINS Bundle, compared to no PINS Bundle, reduces the incidence of adverse tracheal intubation associated events.

The primary objective of this study is to determine the effectiveness of the PINS Bundle to decrease adverse TI safety events. The secondary objectives are 1) to evaluate if the impact of the PINS Bundle on adverse TI safety events varies based on provider skill, and 2) to determine the impact of the PINS Bundle on NICU clinical outcomes of extubation failure, duration of intubation, NICU mortality, and intraventricular hemorrhage.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3000 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Optimizing Tracheal Intubation Outcomes and Neonatal Safety
Actual Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2027
Anticipated Study Completion Date :
Jun 30, 2027

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Pre-Intervention Phase

NICU Patients who are intubated without the PINS Bundle.

Active Comparator: Post-intervention Phase

NICU Patients who are intubated after unit implementation of the PINS Bundle

Other: Personalized Intubation Safety (PINS) Bundle
The Personalized Intubation Safety (PINS) Bundle addresses 5 core domains that are individualized to the patient to develop a prospective, personalized and comprehensive multidisciplinary intubation plan: (1) patient risk assessment; (2) treatment threshold for intubation; (3) premedication (promoting paralytic premedication); (4) equipment (promoting video laryngoscope); (5) provider selection and escalation plan
Other Names:
  • PINS Bundle
  • Outcome Measures

    Primary Outcome Measures

    1. Tracheal intubation associated event (TIAE) [During the intubation procedure, on average 20 minutes]

      Any adverse tracheal intubation associated event (TIAE) during the intubation encounter. In NEAR4NEOS database, a comprehensive group of adverse TIAEs are based on standard consensus-based definitions and classified as severe and non-severe

    Secondary Outcome Measures

    1. Severe TIAE [During the intubation procedure, on average 20 minutes]

      Any severe TIAE, defined by National Emergency Airway Registry for Neonates (NEAR4NEOS) Operational Definitions

    2. Magnitude of oxygen desaturation [During the intubation procedure, on average 20 minutes]

      Difference between highest oxygen saturation (SpO2) value immediately before first intubation attempt and lowest value at any point during the procedure

    3. Number of subjects with multiple intubation attempts (>2 attempts) [During the intubation procedure, on average 20 minutes]

      More than 2 intubation attempts

    4. Duration of mechanical ventilation [Through study completion, on average 90 days]

      Duration of mechanical ventilation after the immediate intubation encounter

    5. Number of subjects requiring reintubation within 24 hours of extubation [Up to 24 hours after extubation]

      Need for reintubation within 24 hours of extubation from the course of ventilation immediately following the intubation encounter

    6. Number of subjects with Intraventricular hemorrhage [Up to 7 days after birth]

      Any intraventricular hemorrhage and grade on head ultrasound, assessed for at risk preterm infants

    7. NICU Mortality [Through study completion, on average 90 days]

      Death before NICU discharge

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 1 Year
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Infants undergoing tracheal intubation in the neonatal intensive care unit (NICU)

    Exclusion Criteria:

    Endotracheal tube exchanges, as this represents a distinct procedure.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Arkansas Medical Sciences Little Rock Arkansas United States 72205
    2 University of Colorado - Denver Denver Colorado United States 80204
    3 Yale-New Haven Hospital New Haven Connecticut United States 06510
    4 Dartmouth-Hitchcock Clinic Lebanon New Hampshire United States 03756
    5 WakeMed Health & Hospitals Raleigh North Carolina United States 27610
    6 Penn State Milton S. Hershey Medical Center Hershey Pennsylvania United States 17033
    7 University of Washington Seattle Washington United States 98195
    8 CHU Sainte-Justine Montréal Quebec Canada QC H3T 1C5

    Sponsors and Collaborators

    • Children's Hospital of Philadelphia
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    • Principal Investigator: Elizabeth Foglia, MD, Children's Hospital of Philadelphia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Children's Hospital of Philadelphia
    ClinicalTrials.gov Identifier:
    NCT05838690
    Other Study ID Numbers:
    • 22-019975
    • R01HD106996
    First Posted:
    May 1, 2023
    Last Update Posted:
    May 1, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Children's Hospital of Philadelphia

    Study Results

    No Results Posted as of May 1, 2023